2023
ARTHEx Biotech Announces Closing of €42 M Series B Financing
03/05/2023ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel Treatment for Myotonic Dystrophy Type 1... Read More
Minoryx presents positive interim results from NEXUS registration study
25/04/2023Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD) Initial evidence... Read More
Dr. Robert Armstrong joins as new partner and Columbus opens Boston office
27/03/2023Columbus Venture Partners opens an office in Boston with the addition of Dr. Robert Armstrong as a new partner of the... Read More
Integra Therapeutics acquires CRISPR licence from CIC nanoGUNE
04/01/20232.6 billion-year-old ancestors of the CRISPR gene-editing tool are resurrected An international study led by Spanish scientists has deciphered the origin... Read More